Normalized claim
Content-piece recall: 90%
Content piece recall of 90%
Flo Health is developing MACROS, an AI-assisted medical automated content review and revision optimization solution for reviewing and updating thousands of medical articles. The system uses Amazon Bedrock with AWS Step Functions, Lambda, S3, API Gateway, and ECS/Streamlit to extract rules, chunk long articles, assess adherence, generate revisions, and support human expert validation.
Reported outcomes
Processing speed: 10×
Time & speed
Catalog median for time & speed deployments: +59% across 138 reported metrics. Compare benchmarks →
Normalized claim
Content-piece recall: 90%
Content piece recall of 90%
Normalized claim
Detection time: 90% decrease
Reduce detection time from hours to minutes per guideline
Normalized claim
Processing speed: 10 x increase
Speed: 10x faster than manual review process
Normalized claim
Accuracy: 80%
maintaining 80% accuracy
Normalized claim
Recall for updates: 90%
over 90% recall in identifying content requiring updates
No explicit deployment-stage evidence found.
Primary read
Showing 2 of 2
MACROS is a custom-built, AI-assisted medical content review and revision optimization system. Users submit PDF, TXT, JSON, or pasted text through a Streamlit UI hosted on Amazon ECS, with authentication via Amazon API Gateway. Files can also be uploaded to Amazon S3. The ECS frontend orchestrates processing with AWS Step Functions. AWS Lambda performs preprocessing such as PDF text extraction. Rule Optimizer, Content Review, and Content Revision functions are orchestrated by Step Functions and call Amazon Bedrock foundation models to extract rules, review article sections against rule sets, generate compliant revisions, and combine revised sections back into the original text. AWS CloudWatch is used for monitoring and log management. The article also mentions future exploration of Amazon Bedrock Flows.
AI-generated summary. Verify important details with the linked sources before relying on this case.
Was this useful?
Community
No published comments yet.